Back to Blog

Ways to Improve IVF Success: Evidence-Based Strategies

Dr. Senai Aksoy · · 6 min read
Medically reviewed on 18 July 2026 - Dr. Senai Aksoy
ivfsuccessstrategiesovarian stimulation
Ways to Improve IVF Success: Evidence-Based Strategies

Key Takeaways

IVF success is improved most reliably by matching treatment to diagnosis, ovarian reserve, age, sperm factors, and prior cycle response. Individualized stimulation, careful embryo transfer strategy, and avoidance of weakly supported add-ons matter more than trend-driven or one-size-fits-all advice.

Key evidence: ESHRE Ovarian stimulation guideline ASRM Embryo transfer limits ASRM Optimizing natural fertility

On this page

Ways to Improve IVF Success

There is no single trick that guarantees IVF success. The strongest improvements usually come from matching the treatment plan to the diagnosis, reducing avoidable risk, and choosing evidence-based decisions over marketing claims about add-ons. Our IVF success rates by age page shows how these factors actually translate into outcomes.

1. Start With an Accurate Diagnosis

Short Answer:

IVF outcomes depend on age, ovarian reserve, sperm quality, and uterine or tubal findings — reviewing these before stimulation makes the cycle more likely to be efficient.

IVF outcomes are shaped by age, ovarian reserve, sperm quality, tubal disease, uterine cavity findings, endometriosis, adenomyosis, metabolic factors, and how the patient responded to prior treatment. Reviewing these before stimulation begins is what makes a cycle more likely to be efficient.

2. Individualize Ovarian Stimulation

Short Answer:

The right stimulation protocol differs by patient — PCOS needs OHSS-conscious dosing, diminished ovarian reserve needs a different medication strategy — and monitoring lets the team adjust safely.

The right stimulation protocol is not the same for every patient. A woman with PCOS (polycystic ovary syndrome) may need an approach that keeps the risk of OHSS (ovarian hyperstimulation syndrome) low, while one with diminished ovarian reserve often needs a different medication strategy — and a realistic conversation about likely egg yield. Monitoring throughout stimulation is what allows the team to adjust treatment safely, catching both over-response and under-response before they become a problem.

3. Use Embryo Transfer Strategy Carefully

Short Answer:

Single embryo transfer usually lowers twin risk without meaningfully reducing cumulative live birth rates when extra embryos are available; fresh versus frozen transfer should follow the cycle, not a blanket rule.

Embryo transfer decisions influence both pregnancy chance and safety. In many patients, single embryo transfer lowers the risk of twins without meaningfully compromising cumulative live birth rates when additional embryos are available. Fresh versus frozen transfer should be chosen based on the cycle, hormone environment, and safety considerations rather than a blanket rule.

4. Treat Major Uterine or Tubal Problems Before Transfer

Short Answer:

Untreated hydrosalpinx, a distorted uterine cavity, or intrauterine adhesions can reduce implantation chances and are usually worth correcting before adding anything else to the plan.

Some findings can reduce the chance of implantation and should be addressed before embryo transfer. Examples include untreated hydrosalpinx, a distorted uterine cavity from selected fibroids or polyps, and some forms of intrauterine adhesions. Correcting the main mechanical problem is usually more useful than adding poorly validated adjuncts later.

5. Do Not Ignore the Male Factor

Short Answer:

A normal IVF label does not make semen analysis optional — sperm factors can change fertilization strategy and help explain prior poor embryo development.

A normal IVF label does not make sperm evaluation optional. Semen analysis — and, in selected situations, further male-factor assessment — can change the fertilization strategy and help explain why embryo development fell short in a previous cycle.

6. Optimize General Health

Short Answer:

Healthy weight, smoking cessation, and treating thyroid disease, diabetes, or hyperprolactinemia support treatment conditions, though they do not replace IVF technique itself.

A number of everyday factors support treatment: healthy weight, quitting smoking, well-managed thyroid disease or diabetes, appropriate treatment of hyperprolactinemia, and a review of current medications. None of this replaces IVF technique itself, but it does improve the conditions the technique has to work with.

7. Be Careful With Add-Ons

Short Answer:

Many add-ons — endometrial scratching, immune therapies, routine ERA testing, PRP, supplements — are not strongly supported for routine use, so invasiveness and evidence quality deserve scrutiny before agreeing to one.

Patients often ask about endometrial scratching, immune therapies, routine ERA testing, PRP, and many supplements. Some interventions may have a role in selected cases, but many are not strongly supported for routine use. If a proposed add-on is expensive, invasive, or framed as universally necessary, it deserves closer scrutiny.

8. Consider Reduced-Medication Protocols When Appropriate

Short Answer:

In selected patients — particularly those with diminished ovarian reserve — a reduced-medication protocol can lower injection burden without compromising outcomes, but it must be matched to the right patient profile, not applied universally.

For some patients — particularly those with diminished ovarian reserve — a reduced-medication approach can lower injection burden and monitoring visits without compromising outcomes. Mandelbaum et al. (2025) showed that extending clomiphene citrate throughout stimulation (without a GnRH antagonist) achieved non-inferior mature oocyte yield with lower premature ovulation rates of 0.3% versus 3.0% in a standard antagonist protocol (Mandelbaum et al., 2025). Zhu et al. (2026) add important nuance: in a network meta-analysis of POSEIDON-group patients, GnRH-agonist protocols yielded significantly higher live birth rates than mild stimulation in POSEIDON group 3, while no difference emerged in group 4. Reduced-medication protocols must therefore be matched to the right patient profile — not applied universally.

Dr Aksoy’s clinical perspective

“I mostly tell my patients this: increasing your chances doesn’t mean adding more to the treatment. Sometimes the most reliable way to improve success is to remove what isn’t necessary.

“When a patient says, ‘I want to try everything I’ve read about online — let’s not leave anything out,’ I first try to understand the anxiety behind that request. After a few failed attempts, couples can start seeing every untried option as a missed opportunity. What I tell them is this: we don’t have to order the whole menu. Let’s first work out at which stage the previous attempt actually lost ground — did too few eggs develop, were too few mature, did fertilisation fail, did the embryo not reach blastocyst, or was a good embryo transferred without implantation? Every method added without identifying the problem makes treatment more expensive and more complicated — but not necessarily more successful.

“My approach isn’t to apply eight methods at once — it’s to go through them in the right order. I start by re-reviewing the diagnosis and prior cycles. Then I individualise stimulation based on age and ovarian reserve, and assess embryo development and transfer timing. The uterine cavity — and the tubes, when relevant — get reviewed; the male factor isn’t waved off with a standard semen count alone. Genuinely modifiable general-health factors — thyroid, metabolic status, weight, smoking, current medications — get addressed. Only after that do I discuss whether an add-on is actually meaningful for that particular patient.

“What bothers me most is adding a new ‘add-on’ after every failed attempt without a scientific rationale — EmbryoGlue, time-lapse, assisted hatching, endometrial scratching, ERA, immune therapies, PRP, or a different lab test each time. Some of these can be reasonable for selected patients, but none of them is the missing magic piece for everyone.

“Another mistake is switching medication or brand after a failed cycle without analysing why it failed in the first place. Changing the box the drug comes in is not the same as changing the treatment strategy — if we can’t say what went wrong or fell short in the previous protocol, we can’t explain why the new brand would do any better.

“My approach to reduced-medication or mini-IVF protocols is the same: less medication isn’t automatically more natural or better, and a higher dose doesn’t automatically mean more eggs. The goal isn’t to use the maximum amount of medication — it’s to get the most appropriate response your ovaries can safely give.

“What I offer the patient in the end is this framework: I can’t promise you success, but I can explain why each recommendation is being made, what problem it’s meant to solve, and how strong the evidence behind it is. If a method doesn’t have a good answer to those three questions, I don’t think it’s right to add it just because ‘it might help.’”

Conclusion

The most reliable way to improve IVF success isn’t adding more treatments indiscriminately — it’s understanding the diagnosis, choosing a protocol that fits the patient, protecting safety, and staying wary of interventions that sound plausible but lack strong evidence.

Request a Case Review

If you want to know which of these strategies actually apply to you — not a generic list — a structured review of your age, ovarian reserve, prior cycles, and diagnosis will tell you more than adding treatments one at a time. You can request a confidential case review and have your file assessed before your next cycle.

FAQ

What improves IVF success most reliably?

The strongest gains usually come from accurate diagnosis, individualized stimulation, careful embryo transfer strategy, and correction of major uterine or tubal problems when present.

Are IVF add-ons always helpful?

No. Some add-ons may help selected patients, but many are weakly supported for routine use. Invasiveness, evidence quality, and how essential the add-on really is should all be discussed openly before you agree to one.

Does lifestyle change replace IVF technique?

No. General health optimization supports treatment conditions, but it does not override age, ovarian reserve, sperm factors, embryo quality, or uterine findings.

Is single embryo transfer less effective?

For many good-prognosis patients, single embryo transfer can reduce twin risk while preserving cumulative live birth chances when additional embryos are available.

Sources

Add as a Preferred Source on Google

You can add draksoyivf.com as one of your preferred health information sources on Google.

Add on Google
Dr. Senai Aksoy

Dr. Senai Aksoy studied and trained in France before returning to Turkey, where he was a founding member of the ICSI team at Sevgi Hospital, Ankara — the country's first ICSI centre (1994-95) — and a co-author on the first Turkish ICSI publications produced in collaboration with the Brussels Van Steirteghem group (Human Reproduction, 1996; PMID 8671323). He helped build the IVF programme at the American Hospital Istanbul and has been running his own fertility practice since 1998.

Verified profiles: PubMed ORCID LinkedIn

Instagram YouTube

The content has been created by Dr. Senai Aksoy and medically approved.